Concepedia

Author

Manja Meggendorfer

Munich Leukemia Laboratory (Germany)ORCID

Also Known As

M Meggendorfer, M. Meggendorfer, Manja Meggendorfer, Meggendorfer, Manja

495

Publications

9.4K

Citations

50

H-Index

107

Concepts

All Affiliations

Munich Leukemia Laboratory (Germany)Heidelberg UniversityCleveland ClinicUniversity Hospital HeidelbergMedical University of Vienna
MM

About

Manja Meggendorfer is an author at Munich Leukemia Laboratory (Germany) specializing in medicine, pathology, and hematology.

Top Concepts

#ConceptH-IndexPublicationsCitations

1

Medicine

26

44

2.7K

2

Health Sciences

9

9

278

3

Engineering

5

5

151

4

Language Studies

1

1

63

5

Management

1

1

28

Manja Meggendorfer

×

106

Publications

7.6K

Citations

46

H-Index

YearCitations

Prognostic Score Including Gene Mutations in Chronic Myelomonocytic Leukemia

Raphaël Itzykson, Olivier Kosmider, Aline Renneville,

Journal of Clinical Oncology

2013

537

Dynamics of clonal evolution in myelodysplastic syndromes

Hideki Makishima, Tetsuichi Yoshizato, Kenichi Yoshida,

Nature Genetics

2016

415

Integrating clinical features and genetic lesions in the risk assessment of patients with chronic myelomonocytic leukemia

Chiara Elena, Anna Gallì, Esperanza Such,

Blood

2016

344

Homozygous BCMA gene deletion in response to anti-BCMA CAR T cells in a patient with multiple myeloma

Matteo Da Vià, Oliver Dietrich, Marietta Truger,

Nature Medicine

2021

314

SRSF2 mutations in 275 cases with chronic myelomonocytic leukemia (CMML)

Manja Meggendorfer, Andreas Roller, Torsten Haferlach,

Blood

2012

304

Mechanisms of antigen escape from BCMA- or GPRC5D-targeted immunotherapies in multiple myeloma

Holly Lee, Sungwoo Ahn, Ranjan Maity,

Nature Medicine

2023

280

Comprehensive mutational profiling in advanced systemic mastocytosis

Juliana Schwaab, Susanne Schnittger, Karl Sotlar,

Blood

2013

252

The impact of TP53 mutations and TP53 deletions on survival varies between AML, ALL, MDS and CLL: an analysis of 3307 cases

Anna Stengel, Wolfgang Kern, Torsten Haferlach,

Leukemia

2016

224

Additional mutations in SRSF2, ASXL1 and/or RUNX1 identify a high-risk group of patients with KIT D816V+ advanced systemic mastocytosis

Mohamad Jawhar, Juliana Schwaab, Susanne Schnittger,

Leukemia

2015

218

Classification and Personalized Prognostic Assessment on the Basis of Clinical and Genomic Features in Myelodysplastic Syndromes

Matteo Bersanelli, Erica Travaglino, Manja Meggendorfer,

Journal of Clinical Oncology

2021

212

Page 1